Alessandro Martorana focuses on Neuroscience, Internal medicine, Alzheimer's disease, Endocrinology and Cognitive decline. His research on Neuroscience frequently links to adjacent areas such as Disease. The Orexin research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Population, therefore creating a link between diverse domains of science.
His studies in Alzheimer's disease integrate themes in fields like Cognition, Default mode network and Electroencephalography. His work on Cholinergic neuron and Striatum as part of his general Endocrinology study is frequently connected to Cyclic guanosine monophosphate, thereby bridging the divide between different branches of science. His Cognitive decline research is classified as research in Dementia.
Alessandro Martorana mainly focuses on Neuroscience, Internal medicine, Endocrinology, Disease and Neuroplasticity. His work on Neuroscience deals in particular with Transcranial magnetic stimulation, Cholinergic, Dopaminergic, Dopamine and Stimulation. His Dopamine research is multidisciplinary, incorporating perspectives in Levodopa and Neurotransmitter.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Cardiology. His Striatum, Globus pallidus and Basal ganglia study in the realm of Endocrinology interacts with subjects such as Quinolinic acid. His study looks at the relationship between Neuroplasticity and topics such as Long-term potentiation, which overlap with Cognitive decline, Synaptic plasticity, Primary motor cortex, Neuropsychology and Biomarker.
His main research concerns Neuroscience, Transcranial magnetic stimulation, Frontotemporal dementia, Neuroplasticity and Disease. His work in Neuroscience is not limited to one particular discipline; it also encompasses Neurodegeneration. His biological study spans a wide range of topics, including Differential diagnosis, Alzheimer's disease, Dementia and Primary progressive aphasia.
The study incorporates disciplines such as Motor cortex, Primary motor cortex, Long-term potentiation and Aphasia in addition to Neuroplasticity. His Disease study combines topics in areas such as Follow up studies, Environmental enrichment, Pediatrics and Successful aging. His Internal medicine research integrates issues from Endocrinology and Frontal lobe.
The scientist’s investigation covers issues in Transcranial magnetic stimulation, Alzheimer's disease, Neuroscience, Frontotemporal dementia and Dementia. Many of his studies on Transcranial magnetic stimulation apply to Neuroplasticity as well. Alessandro Martorana combines subjects such as Long-term potentiation and Cognition with his study of Neuroplasticity.
His Cognition study incorporates themes from Internal medicine and Oncology. His Alzheimer's disease study combines topics in areas such as Adverse effect, Clinical endpoint, Randomized controlled trial and Rotigotine. In his research, Recall, Disease, Neurotransmission, Neuronal degeneration and Lewy body is intimately related to Differential diagnosis, which falls under the overarching field of Frontotemporal dementia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis
Diego Centonze;Luca Muzio;Silvia Rossi;Francesca Cavasinni.
The Journal of Neuroscience (2009)
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Claudio Liguori;Andrea Romigi;Marzia Nuccetelli;Silvana Zannino.
JAMA Neurology (2014)
"Is dopamine involved in Alzheimer's disease?".
Alessandro Martorana;Giacomo Koch.
Frontiers in Aging Neuroscience (2014)
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
Alessandro Martorana;Zaira Esposito;Giacomo Koch.
CNS Neuroscience & Therapeutics (2010)
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease.
Giacomo Koch;Sonia Bonnì;Maria Concetta Pellicciari;Elias P. Casula.
Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?
Zaira Esposito;Lorena Belli;Sofia Toniolo;Giuseppe Sancesario.
CNS Neuroscience & Therapeutics (2013)
Impaired LTP- but not LTD-like cortical plasticity in Alzheimer's disease patients.
Giacomo Koch;Francesco Di Lorenzo;Sonia Bonnì;Viviana Ponzo.
Journal of Alzheimer's Disease (2012)
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients
Alessandro Martorana;Francesco Mori;Zaira Esposito;Hajime Kusayanagi.
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis
Silvia Rossi;Roberto Furlan;Valentina De Chiara;Alessandra Musella.
Neurobiology of Disease (2009)
Dopaminergic Modulation of Cortical Plasticity in Alzheimer’s Disease Patients
Giacomo Koch;Francesco Di Lorenzo;Sonia Bonnì;Viola Giacobbe.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: